Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amniotic band syndrome - a case report of prenatally detected fetal upper limb amputation.

Ceska gynekologie·2026
Same author

Vulvodynia and persistent vulvar pain - diagnosis, treatment, and the role of laser vaporization.

Ceska gynekologie·2026
Same author

Clinically relevant histopathological features and biomarkers in endometrial cancer.

Ceska gynekologie·2026
Same author

ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Staging for endometrial carcinoma FIGO 2023 and its relevance for clinical practice.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2024
Same author

Human papillomavirus infection (HPV) and pregnancy.

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne·2024

Related Experiment Video

Updated: May 11, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

[Pregnancy and multiple sclerosis -outcomes analysis 2003-2011].

P Hanulíková1, R Vlk, E Meluzínová

  • 1Gynekologicko-porodnická 2. LF UK a FN Motol, Praha, Prednosta prof. MUDr. L Rob, CSc. hanulikovap@gmail.com

Ceska Gynekologie
|May 29, 2013
PubMed
Summary

Pregnancy in women with multiple sclerosis (MS) is generally safe, with stable disability and no increased complications. While postpartum relapses occur, they do not impact long-term progression, and delivery modes are similar to the general population.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Experiment Videos

Last Updated: May 11, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Area of Science:

  • Neurology
  • Obstetrics
  • Immunology

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Pregnancy can influence the course of chronic diseases, necessitating careful evaluation in women with MS.

Purpose of the Study:

  • To analyze perinatal outcomes in pregnant women with MS.
  • To assess the impact of pregnancy on MS activity and disability progression.
  • To evaluate factors influencing postpartum relapse rates.

Main Methods:

  • Retrospective analysis of 66 women with MS who delivered between 2003-2011.
  • Neurological follow-up for six months postpartum.
  • Evaluation of pregnancy complications, mode of delivery, analgesia, and breastfeeding on relapse rates.
  • Statistical analysis of collected data.

Main Results:

  • Low relapse rate during pregnancy (6.1%); increased postpartum relapse rate (25.7%) within six months.
  • No significant correlation found between breastfeeding or epidural analgesia and postpartum relapses.
  • Pregnancy did not influence disability progression (EDSS remained stable).
  • Perinatal outcomes, including birth weight and pregnancy complications, were comparable to the general population.

Conclusions:

  • Pregnancy in women with MS is generally safe and does not worsen long-term disability.
  • Hormonal changes during pregnancy may stabilize MS and decrease relapse rates.
  • Postpartum relapse rates increase but do not affect overall disease progression.
  • Mode of delivery, breastfeeding, and epidural analgesia showed no significant impact on postpartum relapse rates.